Respiratory papillomatosis( rrp). Respiratory papillomatosis article
In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in Respiratory papillomatosis( rrp) etiological agent is HPV types 6 and 11 and the respiratory papillomatosis article of the respiratory tract the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the respiratory papillomatosis( rrp) mucosa.
The annual costs of the treatment of this disease are over million USD.
The evolution of the disease decreases respiratory papillomatosis( rrp) quality of the life of the patient and malignancy and death can occur during the disease. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Respiratory papillomatosis article and method: using data from the literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by the HPV types 6 and The treatment respiratory papillomatosis article two objectives: relapses and the reestablishment of the respiratory and phonatory function.